A family of macrodomain proteins reverses cellular mono-ADP-ribosylation

Gytis Jankevicius, Markus Hassler, Barbara Golia, Vladimir Rybin, Martin Zacharias, Gyula Timinszky, Andreas G. Ladurner

Research output: Contribution to journalArticlepeer-review

263 Scopus citations


ADP-ribosylation is a reversible post-translational modification with wide-ranging biological functions in all kingdoms of life. A variety of enzymes use NAD + to transfer either single or multiple ADP-ribose (ADPr) moieties onto distinct amino acid substrates, often in response to DNA damage or other stresses. Poly-ADPr-glycohydrolase readily reverses poly-ADP-ribosylation induced by the DNA-damage sensor PARP1 and other enzymes, but it does not remove the most proximal ADPr linked to the target amino acid. Searches for enzymes capable of fully reversing cellular mono-ADP-ribosylation back to the unmodified state have proved elusive, which leaves a gap in the understanding of this modification. Here, we identify a family of macrodomain enzymes present in viruses, yeast and animals that reverse cellular ADP-ribosylation by acting on mono-ADP-ribosylated substrates. Our discoveries establish the complete reversibility of PARP-catalyzed cellular ADP-ribosylation as a regulatory modification.

Original languageEnglish
Pages (from-to)508-514
Number of pages7
JournalNature Structural and Molecular Biology
Issue number4
StatePublished - May 2013
Externally publishedYes


Dive into the research topics of 'A family of macrodomain proteins reverses cellular mono-ADP-ribosylation'. Together they form a unique fingerprint.

Cite this